According to the American Cancer Society, pancreatic cancer is one of the few cancers for which survival rates have not improved substantially during the last 40 years. The Rolfe Pancreatic Cancer Foundation aims to change that. 

By awarding grants to top scientific minds and premier medical institutions, the Rolfe Foundation champions the early detection research that will turn the tide against pancreatic cancer.

Rolfe Foundation funding is awarded through a rigorous review process that ensures that the Foundation’s funding goes to only the most meticulous researchers. In the past, the Foundation has been proud to enable the work of scientists at first-rate hospitals and leading oncology departments like Johns Hopkins and the University of Chicago.